"10.1371_journal.pone.0091098","plos one","2014-03-13T00:00:00Z","Robert Zivadinov; Michael G Dwyer; Silva Markovic-Plese; Cheryl Kennedy; Niels Bergsland; Deepa P Ramasamy; Jacqueline Durfee; David Hojnacki; Brooke Hayward; Fernando Dangond; Bianca Weinstock-Guttman","Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York at Buffalo, Buffalo, New York, United States of America; Department of Neurology, State University of New York at Buffalo, Buffalo, New York, United States of America; Department of Neurology, Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; EMD Serono, Inc., Rockland, Massachusetts, United States of America","Conceived and designed the experiments: SMP BH FD RZ. Performed the experiments: CK BWG DH. Analyzed the data: BH JD DR. Contributed reagents/materials/analysis tools: MGD NB. Wrote the paper: BWG BH CK DH DR FD JD MGD NB RZ SMP. Contributed to the conception and critical review of the manuscript: BWG BH CK DH DR FD JD MGD NB RZ SMP. Statistical analysis software: BH.","This study was sponsored by EMD Serono, Inc., Rockland, MA, a subsidiary of Merck KGaA, Darmstadt, Germany and by Pfizer, Inc, New York, NY (www.pfizer.com/). B Hayward and F Dangond are employees of EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany. Esther Law and Chris Grantham of Caudex Medical, who assisted in preparing the initial draft of the manuscript, collating the comments of authors and other named contributors, as well as assembling tables and figures, were supported by EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany. Additionally, the authors disclose the following competing interests: R Zivadinov received personal compensation from Teva Pharmaceuticals, Biogen Idec, EMD Serono, Novartis, Bayer and Sanofi-Genzyme for speaking and consultant fees. He also received financial support for research activities from Biogen Idec, Teva Pharmaceuticals, Sanofi-Genzyme, Novartis and EMD Serono. S Markovic-Plese received personal compensation from Genzyme Inc. and EMD Serono for consultant fees. She also received research grants from Biogen Idec, EMD Serono, Genzyme Inc., Teva Pharmaceuticals and Novartis. D Hojnacki has received speaker honoraria and consultant fees from Biogen Idec, Teva Pharmaceuticals, EMD Serono and Pfizer Inc. B Weinstock-Guttman has received honoraria as a speaker and a consultant for Biogen Idec, Teva Pharmaceuticals, EMD Serono, Pfizer, Novartis and Acorda, and has also received research funds from Biogen Idec, Teva Pharmaceuticals, EMD Serono, Pfizer, Novartis, Acorda and Cyberonics. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2014","03","Robert Zivadinov","RZ",11,TRUE,4,3,3,11,TRUE,FALSE,FALSE,0,NA,FALSE
